Despite concerns about stretched valuations and market concentration in mega-cap tech and AI-driven stocks, growth ETFs have continued to attract significantly more investment than value ETFs in 2026. Key growth drivers like the Magnificent Seven and AI themes remain influential, but earnings season shows signs of broadening growth beyond these names. Investors are encouraged to lean into growth thoughtfully by choosing ETFs that balance growth with quality and valuation awareness, such as VFLO, QGRO, and RANK, which focus on free cash flow, stable growth, and analyst-backed momentum respectively. This strategy aims to capture growth potential while managing risk amid ongoing market uncertainties.
Stocks in the defense, pharmaceutical, and industrial sectors saw significant gains driven by strong operational results and strategic acquisitions. T3 Defense Inc. surged 122.18% after reporting record revenue and new orders, boosting investor confi...
The stock market is down significantly due to company-specific news such as acquisitions, missed earnings, and revised outlooks. Key declines include PN Smart Energy dropping over 51% after an acquisition, Inno Holdings falling nearly 48%, and Sportr...
Halper Sadeh LLC is investigating whether shareholders of Supernus Pharmaceuticals, Integer Holdings, and Bowhead Specialty Holdings received fair deals in their recent sales. The law firm is concerned that insiders may have gained financial benefits...
WareMatch has partnered exclusively with ShipPlug to integrate automated FedEx and UPS refund recovery into its platform, allowing 3PL operators and shippers to recover money from late deliveries without changing workflows. ShipPlug's software monito...
Raymond James raised Johnson & Johnson's price target to $280, signaling a 10% upside from current levels. The boost follows strong Q2 revenue growth in its oncology division, which now accounts for nearly 29% of total revenues, driven by key cancer ...
